Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/3/2026 | 233 | 0.0% | 3,914 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 8,968 | 0.0% | 165,577 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 9,101 | 0.0% | 165,571 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 11,722 | 0.0% | 165,819 | 3/31/2025 |
| 2024 Q4 | 2/12/2025 | 9,566 | 0.0% | 143,145 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 8,904 | 0.0% | 126,674 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 10,449 | 0.0% | 126,910 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 9,324 | 0.0% | 106,755 | 3/31/2024 |
| 2023 Q4 | 2/8/2024 | 8,082 | 0.0% | 83,599 | 12/31/2023 |
| 2023 Q3 | 11/7/2023 | 7,425 | 0.0% | 83,916 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 6,687 | 0.0% | 77,148 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 6,439 | 0.0% | 66,220 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 6,208 | 0.0% | 61,708 | 12/31/2022 |
| 2022 Q3 | 11/1/2022 | 4,898 | 0.0% | 57,774 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 4,434 | 0.0% | 53,503 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 3,830 | 0.0% | 49,671 | 3/31/2022 |
| 2021 Q4 | 2/7/2022 | 4,492 | 0.0% | 50,265 | 12/31/2021 |
| 2021 Q3 | 11/4/2021 | 3,363 | 0.0% | 43,516 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 3,631 | 0.0% | 43,516 | 6/30/2021 |
| 2021 Q1 | 5/6/2021 | 3,113 | 0.0% | 41,222 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 3,280 | 0.0% | 37,405 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 2,808 | 0.0% | 36,906 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 3,809 | 0.0% | 30,879 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 2,415 | 0.0% | 28,577 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 2,496 | 0.0% | 29,720 | 12/31/2019 |
| 2014 Q2 | 8/5/2014 | 1,453 | 0.0% | 23,363 | 6/30/2014 |
| 2014 Q1 | 5/7/2014 | 1,702 | 0.0% | 24,955 | 3/31/2014 |
| 2013 Q4 | 2/10/2014 | 1,793 | 0.1% | 25,953 | 12/31/2013 |